Status:
COMPLETED
Pilot Study Evaluating Somatostatin Receptor's PET Imaging to Detect Inflammatory Phases of Myocarditis
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Myocarditis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Infectious myocarditis are frequent, most of the time viral and can evolve to cardiac insufficiency. The diagnosis is difficult because they can mime an acute coronary syndrome. Approximately 10 % of ...
Eligibility Criteria
Inclusion
- Adult subjects who have given their written consent to participate in the study.
- Patients without history of heart disease, hospitalized for acute infarction suspected with positive troponine, normal or subnormal angiography and which have a high probability of acute inflammatory myocardities on the secondarily realized MRI (= 2 criteria of Lake Louise)
- No contraindication to perform a 68Ga-DOTATOC-PET .
- Patient belong to a social security scheme.
Exclusion
- Patients under guardianship or curatorship.
- Pregnancy, breastfeeding and woman of childbearing age without effective contraception
- Impossibility to perform a PET with 68Ga-DOTATOC (patient agitated).
- Impossibility to schedule PET/CT before the deadline = in 7 days since the beginning of the hospitalization.
Key Trial Info
Start Date :
July 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 13 2023
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT03347760
Start Date
July 13 2020
End Date
December 13 2023
Last Update
February 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Véronique ROCH
Vandœuvre-lès-Nancy, France, 54511